Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Arcadia Biosciences, Inc. Director's Dealing 2016

Aug 22, 2016

35424_dirs_2016-08-22_29e2620f-1820-4f90-bf69-a3c357161598.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2016-08-18

Reporting Person: Knauf Vic C. (Director, Chief Scientific Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-08-18 Stock Option (right to buy) $2.14 A 75000 Acquired 2026-08-17 Common Stock (75000) Direct

Footnotes

F1: The option vests as to 25% of the award on the first anniversary of the date of the award (or August 18, 2017) and the remaining 75% thereafter in 36 equal installments beginning August 31, 2017 and continuing on the last day of each of the next 35 months, with the last vesting to occur on July 31, 2020.